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Abstract: 
 
Glaucoma is a chronic ocular disease, which is usually managed with long-term medical therapy, in 
the form of eye drops. Patients intolerant to preservatives in topical medicines, require preservative-
free versions. From early 2011 patients attending Moorfields Eye Hospital (MEH), London, started to 
report recurring problems with the supply of the preservative-free (PF) glaucoma medications 
Timolol, Cosopt and Trusopt. This study investigates the impact of the supply problems of these 
medications at MEH from a patient, administrative and clinical perspective. Information was sought 
by interviewing both patients and hospital staff, and a retrospective case note review between April 
2010 and May 2013. 
 
Many hospital roles, both administrative and clinical, were involved in attempting to resolve the 
impact of the supply problems. All staff reported a considerable increase in their workload. At the 
peak of the problem the glaucoma secretaries received about 150 enquiries per week. 
Notes were retrieved for 83 (66%) of a random sample of 125 patients. The patient notes review 
showed that 22% encountered a supply problem. Of these, over a third attended MEH A&E for 
repeat supplies and 89% eventually had their medication changed.  39 (78%) of a random sample of 
50 patients were interviewed by telephone. 59% reported a supply problem. Of these, a third 
attended MEH A&E for repeat supplies and a half eventually required an alternative medication. 
Patients mentioned going to considerable lengths in their attempts to obtain ongoing supplies in the 
community.  
 
This study shows that medication supply problems can have a major impact on patients and hospital 
services. Drug supply problems occur across many fields of medicine and with increasing frequency.  
The findings of this study highlight the importance of early communication of impending shortages 
between manufacturers and the Department of Health, as recommended in the best practice 
guidelines 
3,4
.  However, in order to minimize the impact of medication shortages on patients, 
clinicians and administrative staff, hospitals and health workers, need immediate notification of 
potential supply problems. 
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Introduction:  
 
Glaucoma is a chronic ocular disease, which is usually managed with long-term medical therapy in 
the form of eye drops. The majority of glaucoma eye drops contain preservatives which maintain the 
sterility of drops and aid penetration of the active agents into the anterior chamber. However, some 
patients are intolerant to preservatives and require preservative-free medications
1
. From early 2011, 
patients started to experience recurring problems with the supply of the preservative-free (PF) 
glaucoma medications Timolol, Cosopt and Trusopt. This study investigates the impact of the supply 
problems of the above PF glaucoma medications at Moorfields Eye Hospital (MEH) from a patient, 
administrative and clinical perspective. 
 
Methods: 
 
Three sources of information were sought to assess the impact of supply problems: - 
 
1. Anecdotal staff report  
Glaucoma consultants, A&E consultants, glaucoma secretaries, glaucoma clerks, patient advice and 
liaison officers (PALS), Moorfields Direct (telephone help line for patients) and pharmacists 
(medicines information service and dispensary) were interviewed. An estimate of the peak number 
of enquiries received per week regarding this problem was sought together with anecdotes of 
consequences of supply problems. 
 
2. Patient notes assessment 
The patient ID numbers of new adult prescriptions of PF Timolol 0.25%, Cosopt and Trusopt were 
determined from the Moorfields Eye Hospital (MEH) pharmaceutical database for the year April 
2010 to March 2011.  A random sample of 125 patients was taken from the total number of patients 
issued new prescriptions. Their notes were reviewed from April 2010 to May 2013 using a 
standardized proforma. This data collection period predated the start of the supply problems.  
Reviewing their notes to present day covered the period of maximum drug supply disruption. Thus 
patients on these drops at the time of the supply problems were maximally targeted for this study. 
Data was collected concerning evidence of supply problems, management change, increased 
hospital visits and additional correspondence. 
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3. Patient interview 
Of the notes that were reviewed (patient notes assessment), the first 50 patients were additionally 
contacted by telephone. Their experience concerning ongoing and regular drug supply was sought. 
Where there had been difficulties further questions were asked regarding attempts to overcome the 
problem and consequences. A supply problem was defined as inability to obtain or having to wait 
more than two weeks to receive the drop. 
 
Results: 
 
1. Anecdotal staff report 
Many hospital employees (including glaucoma clerks, glaucoma secretaries, Moorfields Direct, PALS 
and pharmacists) were involved in attempting to resolve the supply difficulties encountered by 
patients.  Although the number of enquiries varied by role, all staff noted a considerable impact on 
their workload.  The largest load fell upon the glaucoma clerks and the secretaries who, at the peak 
of the problem, received about 200 and 150 enquiries a week respectively. Typically the secretaries 
had to request patient notes from medical records and seek a medical opinion, which in turn 
generated correspondence with the GP and the patient.  
 
Seven of the 10 MEH pharmacists responded. Of these, five reported receiving up to 5 enquiries per 
week, one received 15 a week, and one in Medicines Information (telephone advisory service) 
reported up to 50 a week. The pharmacists then sought medical advice from the glaucoma service. 
MEH Pharmacists also reported patients were confused, distressed, frustrated and angry about the 
situation and anxious about reactions to alternative drops. 
 
The lower peak of enquiries reported by consultants may represent a resolution of a proportion of 
the enquiries by other medical staff (fellows and registrars), who were not sampled in the study. 
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Table 1: Enquiries received by staff at MEH 
 
Staff report Sample Responded (%) Total enquiries per week 
Secretaries  4  4(100) 150 
PALS  2  2(100)  15 
Moorfields Direct  2  2(100)  20 
Glaucoma clerks 13  9(69) 200 
Pharmacists 10  7(70)  85 
Consultants 22 19(82)  50 
TOTAL     520 
 
 
2. Patient notes assessment 
During the year April 2010 to March 2011, 328 new prescriptions were issued to 301 patients. Some 
received dual therapy. 191 received PF Cosopt, 63 PF Trusopt, 73 PF Timolol 0.25% and one PF 
Timolol 0.5%. Notes were retrieved for 83 (66%) of the random sample of 125 patients. A total of 93 
prescriptions were issued to these 83 patients; 59 for PF Cosopt, 15 for PF Trusopt, 18 for PF Timolol 
0.25% and 1 for PF Timolol 0.5%.  
 
• Supply problems where unambiguously stated in the notes for 18/83(22%) patients.  
 
• Patient management impact 
89% (16/18) of patients with supply problems required a management change; 15 had a 
topical therapy change and one was listed for trabeculectomy surgery. The remaining two 
patients had obtained repeat supplies from the hospital (A&E).  
 
• Patient and Service impact 
More than a third (39%) of those with supply problems had attended A&E for repeat 
supplies and/or advice, some on multiple occasions. 7 of the 18 patients with supply 
problems made ten additional visits to hospital. Nine of these visits were to A&E and one 
was to the glaucoma clinic. 
 
 
 
Page 5 of 10
Ophthalmic and Physiological Optics
Ophthalmic and Physiological Optics
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
For Review Only
Figure 1: Summary of patient notes assessment 
 
 
 
 
 
 
 
 
 
 
 
 
 
3. Patient Interview 
It was possible to speak to 39 of the 50 patients telephoned.  
 
• Supply problems were reported by 23/39 (59%) of patients.  
 
• Patient management impact 
52% (12/23) of patients with supply problems required a change in topical therapy. 
 
• Patient and Service impact 
Nearly a third (30%) of those with supply problems attended A&E for repeat supplies and/or 
advice, some on multiple occasions. 13 of 23 reporting supply problems contacted the 
hospital on 22 occasions. These comprised of 10 visits (7 patients) to A&E, 6 visits (4 
patients) to pharmacy and 6 telephone calls (6 patients) to MEH.  
 
Figure 2: Summary of patient interview 
 
 
 
 
 
50 telephoned 
39 interviewed  
23 supply problems (59%) 
 
12 (52%) management change 7 (30%) A&E 
13/23 patients with supply problems generated 22 episodes of contact to MEH 
327 new therapy PF drops 
Random sample = 125 
83 notes retrieved 
18 (22%) supply problems 
16 (89%) management change 7 (39%) A&E 
7/18 patients with supply problems generated 10 episodes of contact to MEH 
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Patient Interview Anecdotes 
Some patients said they travelled long distances to obtain supplies and community pharmacists 
reported having to telephone colleagues in the area to seek out supplies. Here is a sample of the 
anecdotes collected: 
 
• “I was really anxious. The patients should have had some warning.” 
• “I couldn’t get my drops from my local pharmacy. My husband contacted MEH pharmacy 
and came up and collected a supply. I had problems when this ran out so my husband then 
contacted the manufacturer who then contacted the wholesaler. The wholesaler arranged 
for supplies to be sent to my local pharmacist, who now orders well in advance.” 
• “My local pharmacy can’t get my drop so I have to take a long bus ride to one that’s quite far 
away.” 
• “I called all my local pharmacies. I found one five miles away with a one month supply. 
When this ran out I attended A&E” 
• “My pharmacist obtained supplies from pharmacists in the area. When he eventually 
couldn’t get any more I came into A&E and ‘they’ changed my drop to Betagan.” 
 
 
 
Table 2: Summary of supply problems and their consequence, as stated in patients’ notes and 
patient interview 
 
 Sample Responded (%) Supply problems 
(%) 
A&E (%) Management  
Change (%) 
Patient notes 
assessment 
125 83 (66) 18 (22) 7/18 (39) 16/18 (89) 
Patient interview 50 39 (78) 23 (59) 7/23 (30) 12/23 (52) 
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Discussion: 
 
To our knowledge, this represents the first report of the impact of supply problems of topical 
medication in the field of glaucoma. The study found these problems had a considerable impact on 
patients both in terms of seeking ongoing supplies and requiring changes in management. This study 
also shows erratic supply of medication increased the workload of all patient contact points in the 
hospital.  
 
The study only sampled patients receiving new prescriptions of the PF medications and only patients 
identified for the year April 2010 to March 2011. The total number of patients using these PF 
medications, including long standing users, during this period, would have been considerably larger. 
This study may, therefore, underestimate the impact of the erratic drug supply on patients and 
hospital services. 
 
Assessment of patients’ notes revealed 22% of patients had supply problems, compared with 59%  
for those patients interviewed. The lower figure for supply may be due to underreporting by patients 
in clinic and/or under recording of the situation by clinicians in the notes. Of the 22% with supply 
problems (patients’ notes assessment), 89% required a management change. Of the 59% with supply 
problems (patients’ interviewed), 52% required a management change. The 89% may be a 
misleadingly high figure, resulting from underreporting of supply problems in the patient notes, 
whilst the 52% may be a misleadingly low figure as a result of discrepancies in recollection of 
management changes by patients. 
 
Those who had no supply problems were generally either only on the drug for a short period of time, 
regularly visited the hospital and obtained repeat drug supplies from the hospital, or managed to get 
supplies locally. 
 
Assessment of both patients’ notes and interviews revealed that approximately a third with supply 
problems attended A&E, some on multiple occasions, to obtain further supplies or an alternative 
medical solution. This is likely an underestimate, as not all A&E entries are filed in patient records. 
This would have been inconvenient and time consuming for patients and staff. 
 
This study did not investigate cost implications to the Trust. 
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Drug supply problems are not limited to ophthalmology. There is legislation and guidance in place to 
safeguard the supply of medicines. It is a complex, multifactorial issue: 
 
• Article 81 of the European Directive of 2001 was implemented to ensure the appropriate 
and continued supply of medicines; Both manufacturers and wholesalers licensed to trade in 
the UK have a legal duty to ensure that UK patient needs are met. Pharmacists and 
dispensing doctors have ethical obligations to ensure the needs of patients are always put 
first
2
.  
• There is joint Department of Health (DH) Guidance with both the Association of the British 
Pharmaceutical Industry and the British Generic Manufacturers Association entitled 
“Notification and management of medicines shortages” which outlines best practice to 
minimise the impact of any medicine shortage. It recommends that companies communicate 
with the DH as soon as possible about impending shortages that are likely to have an impact 
on patient care, so that options for managing the shortage can be investigated and 
contingency arrangements made. 
3,4
 
 
 
Conclusions: 
 
Glaucoma is a chronic disease that requires long-term medical therapy. Our results show that 
medication supply problems can have a major impact on patients and hospital services.  
 
The findings of this study highlight the importance of early communication of impending shortages 
between manufacturers and the Department of Health, as recommended in the best practice 
guidelines 
3,4
.  However, this information also needs to be available to health workers in direct 
contact with patients as soon as possible.  
 
In order to minimize the impact of medication shortages on patients, clinicians and administrative 
staff, hospitals need immediate notification of potential supply problems. 
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